Who wants to buy shares from a company that needs a lot of capital until phase 3 results are announced? Who wants to buy shares from a company from which you have to wait more than 1,5year before any substantial news will be announced?
I am not even sure they can maintain their $50m market cap. Good news to wait so long, because results are better than expected? If that were the case the IDM board would have halted the trial already b/c of superior efficacy.
News 
Market Data 
Discover 
